Online prediction platforms Polymarket and Kalshi have expanded their offerings to include wagers on United States public health outcomes, drawing sharp criticism from academic experts who cite regulatory loopholes and ethical dangers. Users can now place bets on the number of measles cases in the country, the timing of FDA drug approvals, and whether states will repeal vaccine mandates.
Regulatory Gaps in Health Betting
These platforms operate under a legal classification that distinguishes them from traditional gambling. According to Lia Nower, director of the Center for Gambling Studies at Rutgers University, prediction markets function as financial derivatives overseen by the US Commodity Futures Trading Commission rather than state gambling regulators. This status allows them to bypass state-level consumer protections that typically limit betting harms.
Nower described the current landscape as unregulated, noting that no federal body prescribes minimum guidelines for these operations. Several states have already filed lawsuits alleging the platforms operate as illegal gambling sites. The lack of oversight creates a environment where insiders, such as agency reviewers or legislative staff, could potentially profit from nonpublic information without facing the same restrictions as traditional gamblers.
Public Health and Ethical Concerns
Matthew Eisenberg, chair of health policy and management at the Johns Hopkins Bloomberg School of Public Health, warned that these markets create incentives for leaks rather than direct bribery. He noted that trial participants or drug companies might alter their behavior to influence outcomes, compromising the integrity of medical research. While the platforms position these markets as tools for transparency, critics argue they reward the dissemination of confidential data.
The expansion into health topics also raises concerns about problem gambling. Recent data indicates that nearly 40 percent of young gamblers exhibit some degree of gambling-related risk. Eisenberg pointed out that legalization of betting is linked to increased treatment needs for anxiety and depression among young men, yet prediction markets generate little tax revenue to fund such support services.
Despite the backlash, Kalshi spokesperson Dani Lever defended the clinical trial markets as a pilot program designed to solve structural problems in drug development. She argued that public markets allow scattered insights to reach the broader community, avoiding barriers that typically hide trial outcomes from the public.
Not all experts view the health-specific bets as a major threat to public opinion. Eisenberg cautioned that the prices for these contracts are often too low to reflect genuine sentiment, noting that a small wager on a vaccine schedule does not forecast broader public health trends. However, the physical presence of these platforms in public spaces has already sparked local controversy. A promotional sign for Polymarket in Brooklyn was vandalized within a week, with the betting-related text torn away, signaling immediate community resistance to the normalization of health-related wagering.
Source: The Guardian
